Edition:
India

Tenax Therapeutics Inc (TENX.OQ)

TENX.OQ on NASDAQ Stock Exchange Capital Market

6.65USD
20 Jul 2018
Change (% chg)

$-0.23 (-3.34%)
Prev Close
$6.88
Open
$6.88
Day's High
$6.90
Day's Low
$6.65
Volume
1,243
Avg. Vol
26,817
52-wk High
$15.50
52-wk Low
$4.42

Chart for

About

Tenax Therapeutics, Inc. is a specialty pharmaceutical company. The Company is focused on identifying, developing and commercializing products for the critical care market. The Company's main product is levosimendan. Levosimendan is a calcium sensitizer developed for intravenous use in hospitalized patients with acutely... (more)

Overall

Beta: 1.92
Market Cap(Mil.): $14.39
Shares Outstanding(Mil.): 28.24
Dividend: --
Yield (%): --

Financials

Competitors

  Price Chg
Novartis AG (NOVN.S) CHF82.20 +1.24
Merck & Co., Inc. (MRK.N) $62.52 +0.01
Roche Holding Ltd. (ROG.S) CHF234.00 +2.05
Roche Holding Ltd. (RO.S) CHF238.60 +2.80
Abbott Laboratories (ABT.N) $63.32 -0.46
Bayer AG (BAYGn.DE) €92.05 -0.30
Bayer AG (BAYE.F) -- --
Sanofi SA (SASY.PA) €72.36 +0.25
Eli Lilly And Co (LLY.N) $88.47 -0.96
Bristol-Myers Squibb Co (BMY.N) $56.71 +0.17

Earnings vs. Estimates